Apple opened a massive new health study last week that will track data from hundreds of thousands of iPhone owners who volunteer to participate. The goal is to uncover previously unseen connections ...

Argus raised the firm’s price target on Boston Scientific (BSX) to $130 from $105 and keeps a Buy rating on the shares. The firm sees strong ...

Revolutionary new software for the treatment of atrial fibrillation (AFib) has been rolled out for Irish patients in Dublin’s ...

Boston Scientific announced won CE mark for its navigation-enabled Farawave Nav ablation catheter and Faraview software.

Johnson & Johnson MedTech announced that it intends to resume the rollout of its Varipulse platform in the U.S. after a ...

The tools ideate on Boston Scientific’s Farapulse PFA system, which contributed towards a 172% uptick in the company’s Q4 ...

ALBANY, N.Y. ( NEWS10) — A new device is transforming the type of treatment some heart patients with atrial fibrillation receive. Doctors say it’s safer to use and improving outcomes for those who ...

We recently compiled a list of the 10 Best Momentum Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Executive Vice President and Chief Financial Officer, Daniel J. Brennan, recently engaged in a series of stock transactions, according to a recent SEC filing. The transactions come as the company, now ...

Boston Scientific Corporation (NYSE:BSX), a leader in medical device manufacturing with a market capitalization of $155.77 billion, announced today that Charles J. Dockendorff will not seek ...

Boston Scientific successfully continues with its expansion of operations across different geographies outside the United States.